158 related articles for article (PubMed ID: 348305)
1. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
3. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
4. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
[TBL] [Abstract][Full Text] [Related]
5. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
7. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
[No Abstract] [Full Text] [Related]
9. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
10. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Dundalek E
Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
[No Abstract] [Full Text] [Related]
12. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
13. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
[TBL] [Abstract][Full Text] [Related]
14. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Livingston RB
Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
Eagan RT; Maurer LH; Forcier RJ; Tulloh M
Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
[No Abstract] [Full Text] [Related]
19. [Chemotherapy in bronchogenic carcinoma (author's transl)].
Bruntsch U
Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in bronchogenic carcinoma.
Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
